Siemens Healthineers AG provided earnings guidance for the year 2022. For fiscal year 2022, the company expects comparable revenue growth between 0% and 2% from fiscal year 2021. Excluding revenue from rapid COVID-19 antigen tests, the company expects comparable revenue growth between 5% and 7%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.02 EUR | -0.41% | -1.16% | +0.80% |
Jun. 05 | SIEMENS HEALTHINEERS : Jefferies maintains a Buy rating | ZD |
May. 23 | Ailing hospitals slow down German medical technology sector | DP |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.80% | 63.2B | |
+6.37% | 216B | |
+10.21% | 189B | |
+28.22% | 153B | |
+34.42% | 114B | |
+19.21% | 54.78B | |
+0.13% | 48.47B | |
-4.16% | 38.88B | |
+2.39% | 36.14B | |
+19.65% | 30.23B |
- Stock Market
- Equities
- SHL Stock
- News Siemens Healthineers AG
- Siemens Healthineers AG Provides Earnings Guidance for the Year 2022